GLAXOSMITHKLINE PHARMACEUTICALS Q2 FY25 Results
GLAXOSMITHKLINE PHARMACEUTICALS has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 1,010.77 Cr
- Quarter-on-Quarter (QoQ) Change: 24.07% (Previous Quarter: Rs. 814.65 Cr )
- Year-on-Year (YoY) Change: 5.62% (Same Quarter Last Year: Rs. 956.99 Cr )
Profitability Metrics
- Net Profit: Rs. 252.50 Cr
- QoQ Profit Change: 38.49% (Previous Quarter: Rs. 182.33 Cr )
- YoY Profit Change: 16.09% (Same Quarter Last Year: Rs. 217.51 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 14.67
- QoQ EPS Change: 36.34% (Previous Quarter: Rs. 10.76)
- YoY EPS Change: 14.25% (Same Quarter Last Year: Rs. 12.84)
Performance Summary
Strong
GLAXOSMITHKLINE PHARMACEUTICALS increased profits more than sales, showing they're managing costs well.
This analysis provides a snapshot of GLAXOSMITHKLINE PHARMACEUTICALS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.